Abstract
Short QT syndrome is a malignant cardiac disease characterized by the presence of ventricular tachyarrhythmias leading to syncope and sudden cardiac death. Currently, international guidelines establish diagnostic criteria when QTc is below 340 ms. This entity is one of the main diseases responsible for sudden cardiac death in the pediatric population. In recent years, clinical, genetic and molecular advances in pathophysiological mechanisms related to short QT syndrome have improved diagnosis, risk stratification, and preventive measures. Despite these advances, automatic implantable cardiac defibrillator remains the most effective measure. Currently, six genes have been associated with short QT syndrome, which account for nearly 60% of clinically diagnosed families. Here, we review the main clinical hallmarks of the disease, focusing on the pediatric population.
Similar content being viewed by others
References
Algra A, Tijssen JG, Roelandt JR et al (1993) QT interval variables from 24 h electrocardiography and the two year risk of sudden death. Br Heart J 70:43–48
Gussak I, Brugada P, Brugada J et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99–102
Giustetto C, Di Monte F, Wolpert C et al (2006) Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 27:2440–2447
Anttonen O, Junttila MJ, Rissanen H et al (2007) Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 116:714–720
Giustetto C, Schimpf R, Mazzanti A et al (2011) Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 58:587–595
Villafane J, Atallah J, Gollob MH et al (2013) Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 61:1183–1191
Iribarren C, Round AD, Peng JA et al (2014) Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Ann Noninvasive Electrocardiol 19:490–500
Mazzanti A, Kanthan A, Monteforte N et al (2014) Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol 63:1300–1308
Guerrier K, Kwiatkowski D, Czosek RJ et al (2015) Short QT interval prevalence and clinical outcomes in a pediatric population. Circ Arrhythm Electrophysiol 8:1460–1464
Jorgensen IN, Skakkebaek A, Andersen NH et al (2015) Short QTc interval in males with klinefelter syndrome-influence of CAG repeat length, body composition, and testosterone replacement therapy. Pacing Clin Electrophysiol 38:472–482
Dhutia H, Malhotra A, Parpia S et al (2016) The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes. Br J Sports Med 50:124–129
Brugada J, Gussak I, Brugada P (2014) Short QT syndrome: a predictable story. Cardiology 128:231–233
Suzuki H, Hoshina S, Ozawa J et al (2014) Short QT syndrome in a boy diagnosed on screening for heart disease. Pediatr Int Off J Jpn Pediatr Soc 56:774–776
Priori SG, Blomstrom-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J 2015;36:2757–2759.
Gollob MH, Redpath CJ, Roberts JD (2011) The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 57:802–812
Priori SG, Wilde AA, Horie M et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10:1932–1963
Tulumen E, Giustetto C, Wolpert C et al (2014) PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? Heart Rhythm 11:1024–1030
Villafane J, Young ML, Maury P et al (2009) Short QT syndrome in a pediatric patient. Pediatr Cardiol 30:846–850
Wolpert C, Schimpf R, Veltmann C et al (2005) Clinical characteristics and treatment of short QT syndrome. Expert Rev Cardiovasc Ther 3:611–617
Patel C, Yan GX, Antzelevitch C (2010) Short QT syndrome: from bench to bedside. Circ Arrhythm Electrophysiol 3:401–408
Spears DA, Gollob MH (2015) Genetics of inherited primary arrhythmia disorders. Appl Clin Genet 8:215–233
Giustetto C, Scrocco C, Schimpf R et al (2015) Usefulness of exercise test in the diagnosis of short QT syndrome. Europace 17:628–634
Frea S, Giustetto C, Capriolo M et al (2015) New echocardiographic insights in short QT syndrome: more than a channelopathy? Heart Rhythm 12:2096–2105
Watanabe H, Makiyama T, Koyama T et al (2010) High prevalence of early repolarization in short QT syndrome. Heart Rhythm 7:647–652
Roussel J, Labarthe F, Thireau J et al (2016) Carnitine deficiency induces a short QT syndrome. Heart Rhythm 13:165–174
Spaniol M, Brooks H, Auer L et al (2001) Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 268:1876–1887
Liepinsh E, Vilskersts R, Skapare E et al (2008) Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart. Life Sci 83:613–619
Campbell TJ (1989) Characteristics of cardiac action potentials in marsupials. J Comp Physiol [B] 158:759–762
Kijtawornrat A, Panyasing Y, Del Rio C, Hamlin RL (2010) Assessment of ECG interval and restitution parameters in the canine model of short QT syndrome. J Pharmacol Toxicol Methods 61:231–237
Pott A, Rottbauer W, Just S (2014) Functional genomics in zebrafish as a tool to identify novel antiarrhythmic targets. Curr Med Chem 21(11):1320–1329
Brugada R, Hong K, Dumaine R et al (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109:30–35
Campuzano O, Allegue C, Partemi S et al (2014) Negative autopsy and sudden cardiac death. Int J Legal Med 128:599–606
Perez Riera AR, Paixao-Almeida A, Barbosa-Barros R et al (2013) Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy. Cardiol J 20:464–471
Harrell DT, Ashihara T, Ishikawa T et al (2015) Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome. Int J Cardiol 190:393–402
Bellocq C, van Ginneken AC, Bezzina CR et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394–2397
Moreno C, Oliveras A, de la Cruz A et al (2015) A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome. Cardiovasc Res 107:613–623
Maltret A, Wiener-Vacher S, Denis C et al (2014) Type 2 short QT syndrome and vestibular dysfunction: mirror of the Jervell and Lange-Nielsen syndrome? Int J Cardiol 171:291–293
Villafane J, Fischbach P, Gebauer R (2014) Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia. Cardiology 128:236–240
Righi D, Silvetti MS, Drago F (2016) Sinus bradycardia, junctional rhythm, and low-rate atrial fibrillation in Short QT syndrome during 20 years of follow-up: three faces of the same genetic problem. Cardiol Young 26:589–592
Deo M, Ruan Y, Pandit SV et al (2013) KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia. Proc Natl Acad Sci US A 110:4291–4296
Priori SG, Pandit SV, Rivolta I et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96:800–807
Hattori T, Makiyama T, Akao M et al (2012) A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res 93:666–673
Ambrosini E, Sicca F, Brignone MS et al (2014) Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype. Hum Mol Genet 23:4875–4886
Antzelevitch C, Pollevick GD, Cordeiro JM et al (2007) Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115:442–449
Templin C, Ghadri JR, Rougier JS et al (2011) Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur Heart J 32:1077–1088
Crotti L, Marcou CA, Tester DJ et al (2012) Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol 60:1410–1418
Ergul Y, Ozyilmaz I, Onan SH, Guzeltas A (2015) Short QT syndrome in a 14-year-old patient: the first pediatric case from Turkey. Anatol J Cardiol 15:590–591
Stattin EL, Westin IM, Cederquist K et al (2016) Genetic screening in sudden cardiac death in the young can save future lives. Int J Legal Med 130:59–66
Tristani-Firouzi M (2013) The long and short of it: insights into the Short QT syndrome. J Am Coll Cardiol 63(13):1309–1310. doi:10.1016/j.jacc.2013.11.021
Behere SP, Weindling SN (2015) Inherited arrhythmias: the cardiac channelopathies. Ann Pediatr Cardiol 8:210–220
Acknowledgements
We will thank the support of Daniel Bravo Andreu Foundation and La Caixa foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
R. Pereira and O. Campuzano equally contributed.
Rights and permissions
About this article
Cite this article
Pereira, R., Campuzano, O., Sarquella-Brugada, G. et al. Short QT syndrome in pediatrics. Clin Res Cardiol 106, 393–400 (2017). https://doi.org/10.1007/s00392-017-1094-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-017-1094-1